Strategies for Ongoing Testing and Follow-Up of Patients with Diabetes
Driving Awareness of uACR and eGFR Testing
Release Date: 01/15/2025
eGFR and uACR Testing as a Tool to Guide CKM Care
Driving Awareness of uACR and eGFR Testing
During this final episode of the series, experts discuss the importance of chronic kidney disease awareness, detection, and intervention to achieve optimal outcomes for persons with CKM or cardiovascular-kidney-metabolic conditions. Listen Now!
info_outline
Guideline-Directed Medical Therapy and Shared Decision-Making
Driving Awareness of uACR and eGFR Testing
During this episode, experts discuss utilizing guideline-directed medical therapy (GDMT) to reduce risks of kidney disease, cardiovascular disease, and associated mortality outcomes as well as shared decision-making. Listen Now!
info_outline
Strategies for Ongoing Testing and Follow-Up of Patients with Diabetes
Driving Awareness of uACR and eGFR Testing
Experts discuss strategies for ongoing testing and follow-up of patients with diabetes including the role of new therapies in the setting of chronic kidney disease and cardiovascular disease risk.
info_outline
Early uACR and eGFR Testing to Improve Clinical Outcomes
Driving Awareness of uACR and eGFR Testing
Experts discuss the importance of urine albumin-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR) testing for patients with CKD (chronic kidney disease) relative to the risk of cardiovascular disease (CVD).
info_outline
The Connection between Chronic Kidney Disease and Cardiovascular Disease
Driving Awareness of uACR and eGFR Testing
Experts discuss the common risk factors between chronic kidney disease (CKD) and cardiovascular disease (CVD) and the rate of undiagnosed CKD in persons with CVD, diabetes, and other comorbidities. Learn about new treatments and the need for strategies to prevent CKD.
info_outlineExperts discuss strategies for ongoing testing and follow-up of patients with diabetes including the role of new therapies in the setting of chronic kidney disease and cardiovascular disease risk.